Brief: Quince Therapeutics - On Feb 9, Engaged Lifesci Capital For Strategic Alternatives - SEC Filing

IRulya Therapeutics

12/02/2026 11:14

Feb 12 (Reuters) - Quince Therapeutics Inc QNCX.O:

QUINCE THERAPEUTICS - ON FEB 9, ENGAGED LIFESCI CAPITAL FOR STRATEGIC ALTERNATIVES - SEC FILING

QUINCE THERAPEUTICS - PLANS TO FOCUS ON REVERSE MERGER - SEC FILING

QUINCE THERAPEUTICS - LEAD DRUG CANDIDATE EDSP FAILS IN NEAT TRIAL - SEC FILING

QUINCE THERAPEUTICS: DO NOT HAVE RESOURCES TO PURSUE FURTHER OPERATIONS ON LEAD DRUG CANDIDATE, EDSP

Source text: []

Further company coverage: QNCX.O

 ((Reuters.Briefs@thomsonreuters.com;))